精神分裂症临床分期模型的研究进展

doi:10.3969/j.issn.1006-7795.2018.02.012

首都医科大学学报 ›› 2018, Vol. 39 ›› Issue (2): 213-216.doi: 10.3969/j.issn.1006-7795.2018.02.012

• 精神分裂症基础和临床 • 上一篇下一篇

精神分裂症临床分期模型的研究进展

徐园园¹, 贾竑晓^1,2

1. 首都医科大学附属北京安定医院中西医结合研究室, 北京 100088;
2. 北京市精神疾病诊断与治疗重点实验室, 北京 100088

收稿日期:2018-01-26 出版日期:2018-03-21 发布日期:2018-04-14
通讯作者: 贾竑晓 E-mail:pbchan@hotmail.com
基金资助:
国家科技支撑计划（2007BAI33B01），国家自然科学基金（31472056），广西科技基础条件平台建设项目（20164412-3），南宁市科学研究与技术开发计划项目（20163349）。

The progress on clinical staging model in schizophrenia

Xu Yuanyuan¹, Jia Hongxiao^1,2

1. Chinese Medicine Research Center, Beijing Anding Hospital, Capital Medical University, Beijing 100088, China;
2. Beijing Key Laboratory for Mental Disorders and Treatment, Beijing 100088, China

Received:2018-01-26 Online:2018-03-21 Published:2018-04-14
Supported by:
This study was supported by National Science and Technology Support Plan (2007BAI33B01), National Natural Science Foundation of China (31472056), Guangxi Science and Technology Foundation Platform Construction Project (20164412-3), Nanning Science and Technology Development Plan Project (20163349).

摘要/Abstract

摘要： 本文概述了目前精神分裂症临床分期模型的研究进展。临床分期模型关注疾病的病程和进展，为精神科医生和临床心理学家提供了创新的评估工具。回顾了各研究团队与临床实践指南对疾病各阶段的描述，以及各阶段的临床病程、主要特征、以及适应治疗方案。旨在提高各阶段的有效干预措施和治疗方法，从而阻止精神分裂症的发病或疾病的进展，改善患者预后。

关键词: 精神分裂症, 临床分期, 临床分期模型

Abstract: This paper summarizes the research progress of clinical staging model in schizophrenia. The clinical staging model focuses on the course and progression of diseases and provides innovative assessment tools for psychiatrists and clinical psychologists. We reviewed the description of the different stages, clinical course, main features of each stage, and therapeutic schedule according to research team and clinical practice guidelines. The aim is to improve effective intervention measures and treatment methods of each stage, prevent the onset or the progress of schizophrenia, and improve the prognosis of schizophrenia.

Key words: schizophrenia, clinical staging, clinical staging model

中图分类号:

徐园园, 贾竑晓. 精神分裂症临床分期模型的研究进展[J]. 首都医科大学学报, 2018, 39(2): 213-216.

Xu Yuanyuan, Jia Hongxiao. The progress on clinical staging model in schizophrenia[J]. Journal of Capital Medical University, 2018, 39(2): 213-216.

参考文献

[1] Pallanti S. ICD and DSM:neuroplasticity and staging are still missing[J]. CNS Spectr,2016,21(4):276-278.
[2] Cosci F, Fava G A. Staging of mental disorders:systematic review[J]. Psychother Psychosom,2013,82(1):20-34.
[3] Fava G A, Kellner R. Staging:a neglected dimension in psychiatric classification[J]. Acta Psychiatr Scand,1993,87(4):225-230.
[4] Birchwood M, Todd P, Jackson C. Early intervention in psychosis:the critical period hypothesis[J]. Br J Psychiatry Suppl,1998,172(33):53-59.
[5] Lieberman J A, Perkins D, Belger A, et al. The early stages of schizophrenia:speculations on pathogenesis, pathophysiology, and therapeutic approaches[J]. Biol Psychiatry,2001,50(11):884-897.
[6] Singh S P, Cooper J E, Fisher H L, et al. Determining the chronology and components of psychosis onset:the Nottingham Onset Schedule (NOS)[J]. Schizophr Res,2005,80(1):117-130.
[7] McGorry P D, Hickie I B, Yung A R, et al. Clinical staging of psychiatric disorders:a heuristic framework for choosing earlier, safer and more effective interventions[J]. Aust N Z J Psychiatry,2006,40(8):616-622.
[8] McGorry P D, Purcell R, Hickie I B, et al. Clinical staging:a heuristic model for psychiatry and youth mental health[J]. Med J Aust,2007,187(7 Suppl):S40-S42.
[9] McGorry P D, Nelson B, Goldstone S, et al. Clinical staging:a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders[J]. Can J Psychiatry,2010,55(8):486-497.
[10] Klosterkötter J. The clinical staging and the endophenotype approach as an integrative future perspective for psychiatry[J]. World Psychiatry,2008,7(13):159-160.
[11] Agius M, Goh C, Ulhaq S, et al. The staging model in schizophrenia and its clinical implications[J]. Psychiatry Danub,2010,22(2):211-220.
[12] Galletly C, Castle D, Dark F,et al. Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders[J]. Aust N Z J Psychiatry,2016,50(5):410-472.
[13] Ruiz-Iriondo M, Salaberria K, Echeburúa E. Schizophrenia:analysis and psychological treatment according to the clinical staging[J]. Actas Esp Psiquiatr,2013,41(1):52-59.
[14] Yung A R, Phillips L J, Yuen H P, et al. Risk factors for psychosis in an ultra high-risk group:psychopathology and clinical features[J]. Schizophr Res,2004,67(2-3):131-142.
[15] Yung A R, Phillips L J, Yuen H P, et al. Psychosis prediction:12 month follow up of a high-risk (prodromal) group[J]. Schizophr Res,2003,60(1):21-32.
[16] Karanikas E, Ntouros E, Oikonomou D, et al. Evidence for hypothalamus-pituitary-adrenal axis and immune alterations at prodrome of psychosis in males[J]. Psychiatry Investig,2017,14(5):703-707.
[17] Goldsmith D R, Rapaport M H, Miller B J. A meta-analysis of blood cytokine network alterations in psychiatric patients:comparisons between schizophrenia, bipolar disorder and depression[J]. Mol Psychiatry,2016,21(12):1696-1709.
[18] Stefanovic M P, Petronijevic N, Dunjić-Kostić, et al. Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia[J]. J Psychiatr Res,2016,73:45-52.
[19] McGorry P, Keshavan M, Goldstone S, et al. Biomarkers and clinical staging in psychiatry[J]. World Psychiatry,2014,13(3):211-223.
[20] Li T, Wang Q, Zhang J, et al. Brain-wide analysis of functional connectivity in first-episode and chronic stages of schizophrenia[J]. Schizophr Bull,2017,43(2):436-448.
[21] Bartholomeusz C F, Cropley V L, Wannan C. Structural neuroimaging across early-stage psychosis:aberrations in neurobiological trajectories and implications for the staging model[J]. Aust N Z J Psychiatry,2017,51(5):455-476.
[22] Wójciak P, Remlinger-Molenda A, Rybakowski J. Stages of the clinical course of schizophrenia-staging concept[J]. Psychiatr Pol,2016,50(4):717-730.
[23] Duffy A, Malhi G S, Grof P. Do the trajectories of bipolar disorder and schizophrenia follow a universal staging model?[J]. Can J Psychiatry,2017,62(2):115-122.

精神分裂症临床分期模型的研究进展

The progress on clinical staging model in schizophrenia

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	廉思源, 吴涵, 韩金祥, 肖存利, 任艳萍, 金文青, 王雯, 马辛. 影响精神分裂症自我报告康复效果的因素[J]. 首都医科大学学报, 2022, 43(2): 233-238.
[2]	李莉, 刘超猛, 任艳萍, 杨春林, 马辛. 改良电休克治疗首发精神分裂症的研究进展[J]. 首都医科大学学报, 2022, 43(2): 249-253.
[3]	郭城伟, 周娇娇, 冯媛, 杨蕴萍. 精神分裂症患者与正常人自尊水平的对照研究[J]. 首都医科大学学报, 2022, 43(2): 294-298.
[4]	陈溪, 马登磊, 李林. 淫羊藿苷对cuprizone诱导精神分裂症样小鼠模型行为学变化、髓鞘脱失及神经炎性反应的影响[J]. 首都医科大学学报, 2021, 42(5): 761-767.
[5]	宁艳哲, 朱虹, 宋楠, 郑思思, 李自艳, 李佳佳, 马睿, 贾竑晓. 石珍安神颗粒改善精神分裂症前驱期患者认知损害的临床观察[J]. 首都医科大学学报, 2021, 42(3): 404-407.
[6]	仪玉伟, 闫芳, 靳玉宏, 肖存利. 精神分裂症住院患者危险行为的影响因素分析[J]. 首都医科大学学报, 2021, 42(2): 323-327.
[7]	沙莎, 赵希希, 韩传亮, 彭兴, 张培, 董雯, 尹晶晶, 王长明. 精神分裂症静息态下alpha活动和认知水平的相关性[J]. 首都医科大学学报, 2021, 42(1): 117-124.
[8]	张颖, 王若梅, 李刚. 稳定期精神分裂症患者认知功能、情绪管理水平及其影响因素分析[J]. 首都医科大学学报, 2021, 42(1): 143-147.
[9]	刘鑫垚, 马超, 贾竑晓. 精神分裂症认知损害动物模型的研究现状[J]. 首都医科大学学报, 2020, 41(1): 50-54.
[10]	马超, 贺毅, 孙作厘, 刘鑫垚, 冯正田, 陈沛, 宁艳哲, 朱虹, 尹冬青, 贾竑晓. 基于16S rRNA技术分析石珍安神汤对脱髓鞘小鼠肠道菌群多样性的影响[J]. 首都医科大学学报, 2020, 41(1): 64-70.
[11]	何笑笑, 周福春, 王传跃, 朱辉, 及晓, 关鸿志. 精神科急诊紧张症临床特征分析[J]. 首都医科大学学报, 2019, 40(5): 688-692.
[12]	庄文旭, 张伟波, 朱有为, 朱益, 蔡军. 对精神分裂症躯体健康问题的生活方式干预[J]. 首都医科大学学报, 2019, 40(5): 698-702.
[13]	马超, 贾竑晓. 精神分裂症的神经炎性反应研究现状[J]. 首都医科大学学报, 2019, 40(2): 205-208.
[14]	吴燕, 孙作厘, 马超, 朱虹, 尹冬青, 贾竑晓. 中药益肾平肝方对脱髓鞘模型小鼠社会交互行为的影响及作用靶点[J]. 首都医科大学学报, 2019, 40(2): 209-213.
[15]	尹冬青, 黄芳, 赵安全, 王群松, 马雁冰, 陈进东, 李宝君, 都弘, 贾竑晓. 精神分裂症中医证候要素诊断量表初步研究[J]. 首都医科大学学报, 2018, 39(6): 821-827.